Clinical Trial Update: Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes [NA]

View source ↗

Summary

A completed clinical trial sponsored by DexCom evaluated the use of multiple daily injections in conjunction with continuous glucose monitoring for diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: DexCom, Inc. | Conditions: Diabetes Mellitus | NA | Status: COMPLETED